Corvert: Package Insert / Prescribing Info - Drugs.com
2024年1月31日 · CORVERT Injection (ibutilide fumarate injection) is an antiarrhythmic drug with predominantly class III (cardiac action potential prolongation) properties according to the Vaughan Williams Classification.
Ibutilide - Wikipedia
Ibutilide is marketed as Corvert by Pfizer. Administration resulted in successful heart rhythm control in 31–44% of patients within 90 minutes, with sustained polymorphic ventricular tachycardia in 0.9–2.5% of patients. It appears to show better results in atrial flutter as compared to atrial fibrillation. [1]
CORVERT® (ibutilide fumarate) | Pfizer Medical Information - US
CORVERT® (ibutilide fumarate) medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the prescribing information, announcements, resources, and channels to connect with Pfizer Medical Information
CORVERT® | Pfizer
CORVERT® (ibutilide fumarate injection) This product information is intended only for residents of the United States. for Consumers: CORVERT - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources; for Healthcare professionals: CORVERT U.S. Physician Prescribing Information
CORVERT® Description - Pfizer Medical Information - US
CORVERT Injection (ibutilide fumarate injection) is an antiarrhythmic drug with predominantly class III (cardiac action potential prolongation) properties according to the Vaughan Williams Classification.
Corvert Uses, Side Effects & Warnings - Drugs.com
2024年10月4日 · Corvert is an anti-arrhythmic heart medication that corrects certain conditions of irregular heart rhythm. Corvert is used to help keep the heart beating normally in people with certain heart rhythm disorders of the atrium (the upper chambers of the heart that allow blood to flow into the heart).
Corvert (Ibutilide Fumarate Injection): Side Effects, Uses ... - RxList
2024年5月8日 · CORVERT Injection is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Patients with atrial arrhythmias of longer duration are less likely to respond to CORVERT. The effectiveness of ibutilide has not been determined inpatients with arrhythmias of more than 90 days in duration.
Corvert (Pharmacia & Upjohn Company LLC): FDA Package Insert
2024年1月25日 · CORVERT Injection (ibutilide fumarate injection) is an antiarrhythmic drug with predominantly class III (cardiac action potential prolongation) properties according to the Vaughan Williams Classification.
CORVERT-美国FDA药品数据库-药物在线
商品名:corvert,活性成分:ibutilide fumarate,申请号:020491,申请人:pfizer
NDC Package 0009-3794-01 Corvert Injection, Solution …
CORVERT Injection is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Patients with atrial arrhythmias of longer duration are less likely to respond to CORVERT. The effectiveness of ibutilide has not been determined in patients with arrhythmias of more than 90 days in duration.